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Abstract
Reprogramming of somatic cells into inducible pluripotent stem cells generally occurs at low efficiency, although what
limits reprogramming of particular cell types is poorly understood. Recent data suggest that the differentiation status of the
cell targeted for reprogramming may influence its susceptibility to reprogramming as well as the differentiation potential of
the induced pluripotent stem (iPS) cells that are derived from it. To assess directly the influence of lineage commitment on
iPS cell derivation and differentiation, we evaluated reprogramming in adult stem cell and mature cell populations residing
in skeletal muscle. Our data using clonal assays and a second-generation inducible reprogramming system indicate that
stem cells found in mouse muscle, including resident satellite cells and mesenchymal progenitors, reprogram with
significantly greater efficiency than their more differentiated daughters (myoblasts and fibroblasts). However, in contrast to
previous reports, we find no evidence of biased differentiation potential among iPS cells derived from myogenically
committed cells. These data support the notion that adult stem cells reprogram more efficiently than terminally
differentiated cells, and argue against the suggestion that ‘‘epigenetic memory’’ significantly influences the differentiation
potential of iPS cells derived from distinct somatic cell lineages in skeletal muscle.
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Introduction
Skeletal muscle is a complex tissue composed primarily of
multinucleated fibers, but also containing at least two distinct stem
cell populations (muscle-forming satellite cells and non-myogenic
mesenchymal precursors). Self-renewing muscle satellite cells can
be isolated by fluorescence activated cell sorting (FACS) on the
basis of their expression of a unique constellation of cell surface
markers [1]. CD452 Mac12 Sca12 b1-integrin+ CXCR4+
satellite cells, (hereafter referred to as skeletal muscle precursors, or
‘‘SMPs’’) express the canonical satellite cell transcription factor
PAX7, and exhibit muscle-specific stem cell activity in both in vitro
clonogenic assays and in vivo transplant settings [2,3,4]. The
differentiated daughters of SMPs (myoblasts) can likewise be found
in association with skeletal myofibers in adult muscle and isolated
by surface marker staining and cell sorting [4], but these cells
express increased levels of muscle differentiation markers and are
unable to engraft mature myofibers or reconstitute the satellite cell
compartment upon intramuscular transplant. Finally, adult muscle
is also home to a developmentally distinct population of bipotent,
mesenchymal progenitors, which are marked by surface expression
of Sca-1 [2,3] and undergo both fibrogenic and adipogenic
differentiation in vitro and in vivo [2,3,5,6].
Recent studies indicate that while reprogramming of somatic
cells into induced pluripotent stem (iPS) cells generally occurs at
low efficiency, immature blood stem and progenitor cells
reprogram very efficiently (up to 28% of input cells; [7]),
compared to their terminally differentiated daughters. Intriguing-
ly, iPS cells derived from hematopoietic lineages were reported to
exhibit biased differentiation to form blood cells in hematopoietic
colony-forming assays [8], and a recent study reported similar
lineage-biased differentiation among iPS cells reprogrammed from
blood vessel-associated mesoangioblasts [5]. Thus, to test whether
adult stem cells in other mesodermal tissues likewise exhibit
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26406superior reprogramming efficiency and retain an epigenetic
memory that biases their differentiation potential, we examined
reprogramming and differentiation capacity among stem and
progenitor cells of the myogenic [2,4] or fibrogenic/adipogenic
[3,5] lineages found in adult mouse skeletal muscle. Our data
indicate that, as in the hematopoietic system, myogenic and
fibrogenic/adipogenic stem cells show enhanced reprogramming
efficiency in comparison to their differentiated daughters.
However, in contrast to prior reports [5,8,9], we find no evidence
for biased differentiation among SMP-derived iPS cells. These
data support the existence of cell-intrinsic barriers to efficient
reprogramming, which are raised during the process of tissue-
specific differentiation, and argue against suggestions that lineage-
specific epigenetic marks left behind following reprogramming
significantly restrict the developmental potential of somatically
derived iPS cells.
Results
Isolation of myofiber-associated cells from a
reprogrammable mouse for reprogramming
To investigate the reprogramming efficiency of muscle-resident
stem and progenitor populations, we expressed the four canonical
reprogramming factors (Oct4, Sox2, Klf4, c-Myc) [10] using a
‘‘secondary reprogramming system’’ [11,12,13]. In this system,
primary iPS cells were generated first by infection of neonatal tail-
tip fibroblasts, carrying the ROSA-rtTA transactivator, with
lentiviruses expressing Oct4, Sox2, Klf4 and cMyc, each under
the control of a doxycycline (dox)-inducible promoter (Figure S1)
[14]. The resulting iPS cells were injected into mouse blastocysts,
where they produced fetal liver cells that were then differentiated
in vitro into CD8
+ cells, and then re-induced with dox to produce
(secondary) iPS cells that were used to generate ‘‘reprogrammable
mice’’ [13,14]. Cells harvested from these mice could be converted
into iPS cells upon exposure to dox (which activates re-expression
of the integrated reprogramming factors in the transgenic cells of
these animals). Importantly, the integrated reprogramming factors
in these chimeric mice are maintained in an identical genomic
configuration in all iPS cell-derived somatic cells. Therefore this
system allows direct comparison of the reprogramming efficiencies
of distinct cell populations and lineages harvested from these mice,
without potential complications arising from differences in
lentiviral transduction efficiency or variation in integration sites.
SMPs were isolated by two-step enzymatic digestion of skeletal
muscle, followed by fluorescence activated cell sorting (FACS) for
the cell surface marker profile: CD45
2 Mac-1
2 Sca-1
2 b1-
integrin
+ CXCR4
+ (CSM4B) (Figure 1A) [2,4]. Consistent with
previous publications [2,4,6,15] , isolated SMPs showed potent
myogenic potential and were never observed to form fibroblasts or
adipocytes, even under adipogenic culture conditions (Figure 1B).
In addition to SMPs, we also isolated from skeletal muscle a
distinct population of non-myogenic CD45
2 Mac-1
2 Sca-1
+
mesenchymal progenitor cells, referred to here as ‘‘Sca1
+ cells’’,
which both self-renew and possess bipotent fibrogenic and
adipogenic differentiation potential [2,3,5,6] (Figure 1). Finally,
to assess the effects of differentiation on reprogramming efficiency,
we isolated a third population of CD45
2 Mac-1
2 Sca-1
2
CXCR4
2 cells, hereafter referred to as ‘‘CXCR4
2 cells’’, which
is composed of differentiated myoblasts and fibroblasts that lack
self-renewal activity (Figure 1 and [4]). This approach allowed us
to directly compare the reprogramming potential of three distinct
cell populations residing in an identical microenvironmental
‘‘niche’’, including both lineally distinct self-renewing tissue stem
cells (SMPs and Sca1
+ cells) and the more differentiated, non-self-
renewing progeny of such cells (CXCR4
2 cells).
Figure 1. Isolation and differentiation potential of myofiber-associated skeletal muscle precursors (SMPs) and Sca-1+ mesenchymal
progenitors. (A) Myofiber-associated cells were isolated from mouse hind limb muscles and triceps. SMPs were isolated by FACS as CD452 Mac12
Sca12 b1-integrin+ CXCR4+, while bipotent, adipogenic/fibrogenic cells were identified and isolated as CD452 Mac12 Sca-1+ (abbreviated Sca1+;
[3,6]). All cell populations were double-sorted, yielding highly purified cell populations that subsequently were seeded onto irradiated MEFs in the
presence of doxycyline (see Figure 2). (B) SMPs but not Sca1+ cells can differentiate into myosin heavy chain+ (MyHC+) cells, indicating their
myogenic differentiation potential (bottom panel). Conversely, Sca1+ cells but not SMPs can form adipogenic cells, as indicated by Oil-Red-O staining
(top panel). CXCR42 cells are a mixture of myoblasts (bottom panel) and fibroblasts, some of which can adopt an adipocytic fate under adipogenic
culture conditions (top panel).
doi:10.1371/journal.pone.0026406.g001
Skeletal Muscle Stem Cell iPS Cells
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reprogram efficiently
To quantify reprogramming efficiencies, iPS colonies arising
from each dox-induced cell population were identified by
morphological criteria and counted at day 21 after dox induction.
We observed a significantly greater number of iPS colonies
emerging from seeded SMPs, compared to more differentiated
CXCR4
2 cells. In particular, while seeded SMPs formed iPS
colonies with an average uncorrected reprogramming efficiency of
1.8% (n=2 experiments, range=0.7–2.8%) and Sca1+ cells
formed iPS colonies with an average uncorrected reprogramming
efficiency of 0.04% (n=2 experiments, range=0.01–0.07%), we
obtained no iPS colonies from CXCR4
2 cells (Figure S2).
Importantly, the iPS cell lines generated from both SMPs and
Sca-1
+ cells were demonstrated to be pluripotent by in vitro staining
for the pluripotency markers Oct-4, SSEA-1 and alkaline
phosphatase (Figure 2A–D). Moreover, blastocyst injection of
two ‘‘SMP-iPS’’ lines each produced mice showing a high degree
of SMP-iPS cell chimerism, including germline contribution and
transmission (Figure 2E,F, and data not shown).
The data presented above seem to indicate a significantly
increased rate of successful iPS cell derivation from tissue-resident
stem/progenitor cells (both SMPs and Sca1+ cells) in comparison
to their differentiated daughters (CXCR42 cells) residing in the
same anatomical location; however, given that the chimeric mice
from which SMPs and CXCR42 cells were isolated for these
initial experiments contained both transgenic (iPS-derived,
containing the dox-inducible reprogramming factors) and non-
transgenic (host blastocyst-derived) cells, the uncorrected repro-
gramming efficiencies reported above likely underestimate the true
efficiency of target cell reprogramming. To more accurately
determine the reprogramming efficiency of these cells, in a
subsequent series of experiments, we utilized reprogrammable
mice carrying the four doxycycline-inducible transgenic repro-
gramming factors, as before, but additionally labeled the
pluripotent cells that gave rise to these chimeric mice with a
lentivirus constitutively-expressing tdTomato [14]. This strategy
allowed us to prospectively isolate only the transgenic ‘‘repro-
grammable’’ cells, thereby enabling more accurate determination
of reprogramming efficiency (Figure S3). Using this improved
system, we found that the average efficiency of derivation of iPS
colonies from bulk-sorted tdTomato
+ SMPs was ,10% after 3
weeks (n=2 independent experiments), whereas again no iPS
colonies arose from CXCR4
2 cells (n=3 independent experi-
ments), suggesting that their reprogramming efficiency is too low
to be detected under our experimental conditions (Table 1).
Single-cell cloning confirms higher SMP and Sca1+ cell
reprogramming efficiency
To exclude the possibility that the study described above might
overestimate the reprogramming efficiency of target cell popula-
tions after bulk-sorting, by counting ‘‘satellite colonies’’ emerging
from primary iPS colonies, we next performed clonal assays in
which TdTomato
+ SMPs, Sca1
+ cells, or CXCR4
2 cells were
sorted at one cell per well in a 96-well format (Figure 3). To ensure
accurate deposition of a single cell in each well, cells were sorted
directly into wells that already contained irradiated MEFs, and
reprogrammed by addition of doxycycline-supplemented medium.
After 2–3 weeks, colonies with iPS morphology emerged in several
wells, and with subsequent passaging, these colonies developed
into dox-independent iPS lines (as verified by in vitro staining of
pluripotency markers, data not shown). In these clonal assays,
SMPs gave rise to iPS lines at a frequency of 3–10% (number of
iPS colonies derived divided by the number of wells seeded with
SMPs), while again no iPS colonies were detected in wells seeded
with differentiated CXCR4
2 cells (Table 2, column 3).
However, previous work informed us that single-cell sorting and
plating of SMPs in 96-well plates does not occur with absolute
efficiency [2,4]. Hence, we also determined the clonal plating
efficiency of SMPs by seeding single-cells into 96-well plates
without inducing reprogramming, and counting the number of
wells containing live cells after a week. Plating efficiencies of SMPs
varied from 15–25% (Table 2, column 4), and so, using similar
plating efficiencies for cells sorted under induced reprogramming
conditions, we calculate that the actual efficiency of iPS derivation
from SMPs averages 23% (63%), and can reach up to 28%
(Table 2, columns 5 and 6). We obtained similar reprogramming
efficiencies with Sca1
+ cells (Table 2). Thus, in light of the fact that
the differentiated progeny of SMPs and Sca-1
+ cells – CXCR4
2
myoblasts and fibroblasts – reprogram at very low to undetectable
efficiencies (Figures 2 and 3; note also that, using this identical
system, Eminli et al. (2009) reported a reprogramming efficiency of
differentiated fibroblasts from tail tip of only 0.74%), these data
support the notion that adult stem and progenitor cells may be
Figure 2. SMPs and Sca-1+ mesenchymal progenitors reprogram into pluripotent iPS cells with high efficiency. (A–F) iPS cells
generated from SMPs (‘‘SMP iPS’’ cells) show embryonic stem cell-like morphology (A), and stain for the pluripotency markers Oct 4 (B) and SSEA-1
(C). Brightfield and corresponding fluorescence images (red) are shown for B and C. SMP iPS cells also show alkaline phosphatase activity (D). When
SMP iPS cells were injected into C57Bl/6 blastocysts, the resulting chimeras had agouti coat color (E), indicating contribution of the SMP iPS cells to
chimeric tissues. Offspring from matings between SMP iPS cell chimeric mice and C57Bl/6 mice have brown coat color (F), demonstrating the capacity
of SMP iPS cells to provide germline transmission.
doi:10.1371/journal.pone.0026406.g002
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their terminally differentiated counterparts.
Significantly, the higher efficiency of reprogramming of SMPs
and Sca1+ cells was not attributable to higher endogenous
expression of reprogramming factors (Oct4, Sox2, Klf4 and c-
Myc). Quantitative real-time PCR, performed on freshly isolated
cell populations, revealed that none of the myofiber-associated cell
populations studied here expresses appreciable levels of Oct4 or
Sox2, as compared to pluripotent cells (Figure 4). In addition,
SMPs and CXCR42 cells, which show discrepant reprogramming
efficiency (Figures 2 and 3), expressed Klf4 and c-Myc at levels
significantly greater than Sca1+ cells, which show an efficiency of
reprogramming equivalent to SMPs, and much greater than
differentiated CXCR42 cells (Figures 2, 3, and 4). Likewise,
although previous reports have suggested that proliferation rate
may influence the reprogramming efficiency of somatic cells
[16,17], we found no significant differences in the rate of
proliferation of SMPs, Sca1+ cells and CXCR42 cells, based on
direct cell counting and on incorporation of bromodeoxyuridine in
cultured cells (data not shown). These data are consistent with our
previous studies [7], in which varying proliferation rates of
hematopoietic precursor cells did not affect reprogramming
efficiency. Thus, these data indicate that reprogramming efficiency
does not correlate with endogenous expression levels of repro-
gramming factors, suggesting that other attributes, unique to adult
stem cell populations, are responsible for the enhanced repro-
gramming efficiency of these cells.
Teratomas formed from SMP iPS cells do not display
biased differentiation towards somatic cell lineage of
origin
Recent reports have suggested that early passage iPS cells retain
an ‘‘epigenetic’’ memory of their somatic cell of origin, which
influences their subsequent differentiation potential [8,18].
Therefore, we sought to investigate if differences in cell-of-origin
might translate into differences in muscle lineage differentiation
capacity for iPS cells generated from myogenic SMPs or from non-
myogenic Sca1+ cells. iPS cells generated from these two different
cells-of-origin were compared to conventionally derived mES cells
Table 1. TdTomato+ skeletal muscle precursors (SMPs), myoblasts (CXCR42 cells) and bipotent mesenchymal progenitors (Sca1+
cells) were sorted onto irradiated MEFs.
Cell type Efficiency of reprogramming % (No of iPSC colonies/No of cells seeded)
Average efficiency of
reprogramming +/2 standard
error of mean
Expt 1 Expt 2 Expt 3
Skeletal muscle progenitors
(Sca12 CD452 Mac12 b1-
integrin+ CXCR4+; ‘‘SMPs’’
in text)
11% (46/430) 10% (30/300) ND 10.3+/20.3%
Mesenchymal progenitors
(Sca1+ CD452 Mac12;
‘‘Sca1+ cells’’ in text)
ND 9% (28/300) 10% (48/500) 9.5+/20.1%
Myoblast-containing
population (Sca12
CD452 Mac12 CXCR42;
‘‘CXCR42 cells’’ in text)
0% (0/1352) 0% (0/300) 0% (0/500) 0+/20%
Dox was added to induce transgenic expression of Oct4, Sox2, Klf4 and c-Myc. After three weeks, the number of iPS colonies with embryonic stem cell-like morphology
was counted. Data are presented as a percentage of input cells and number of iPS colonies per number of cells seeded. ND: not determined.
doi:10.1371/journal.pone.0026406.t001
Figure 3. Clone-sorted myofiber-associated stem cells reprogram at high efficiency. (A) Experimental strategy for clone-sorting and
reprogramming sorted cells. Myofiber-associated cells from transgenic mice carrying dox-inducible transgenes (Oct4, Sox2, c-Myc, Klf4) and labeled
with constitutively-expressed Tdtomato [22], were double-sorted for purity, and seeded into 96-well plates, at one cell per well, on irradiated MEFs.
After three weeks in dox-containing media, emergent colonies were trypsinized and passaged in the absence of dox, and iPS lines were established
which showed embryonic stem cell-like morphology, stained for the pluripotent marker SSEA-1, and showed alkaline phosphatase activity (data not
shown).
doi:10.1371/journal.pone.0026406.g003
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NOD/SCID mice. These experiments used only early passage
iPS cells (3–5 passages after emergence from reprogramming
conditions), as iPS cells have been reported to lose epigenetic
markers of their somatic cell-of-origin after 5–6 passages [8].
Teratomas were obtained from injection of each pluripotent
cell line, and harvested when they reached a diameter of
,0.5 cm, typically 14–21 days after injection. No differences in
tumor size were observed for iPS- vs. ES-derived teratomas (data
not shown). In addition, in all cases, the injected cells formed
tumors containing cells from all three germ layers, a pattern of
cell fate specification consistent with the pluripotent nature of iPS
and mES cells (Figure 5A and 6). Histological assessment
confirmed the presence of neural cells, cartilage, adipose,
columnar epithelium and keratinocytes in all teratomas
(Figure 5A and data not shown); however, in all cases, skeletal
muscle comprised only a small fraction (2–4%) of tumor mass
(Figure 5B). Importantly, teratomas derived from SMP iPS cells
did not generate skeletal muscle to a significantly higher degree
than teratomas initiated by Sca1+ cell-derived iPS, or by mES,
despite the clearly superior myogenic differentiation potential of
SMPs as compared to other cell types present in skeletal muscle
([2,4], and Figure 1B). Moreover, although Sca1+ cells possess no
intrinsic myogenic capacity when isolated from skeletal muscle
(Figure 1B and [2,3,4,6]), Sca1+ cell derived iPS showed no
impairment in differentiation to the muscle lineage in these
teratoma assays (Figure 5B). Overall, teratomas derived from
Sca1+ iPS, SMP iPS, and mES cells contained an equivalent
representation of muscle cells as assessed by histology (Figure 5B).
This semiquantitative observation was corroborated by Western
blot analysis, which showed no significant differences in the
presence of skeletal muscle myosin heavy chain in teratomas
derived from Sca1+ iPS, SMP iPS, or mES cells (Figure 6B),
indicating equivalent differentiation along the skeletal muscle
lineage. Furthermore, teratomas from Sca1+ iPS, SMP iPS, or
mES cells each contained mesoderm (indicated by myosin heavy
chain, MyHC), ectoderm (indicated by cytokeratin 14, CK14)
and endoderm (indicated by cytokeratin 8, CK8) (Figure 6A) at
roughly equivalent levels (Figure 6B). These data indicate that
none of the pluripotent stem cell types generated here were
deficient in differentiation into any of the three germ layers.
Table 2. The relative efficiencies of reprogramming for each population are shown, before and after normalization for cloning
efficiency.
Cell type
No. iPS colonies/no. input cells
(Reprogramming efficiency %) Cloning efficiency
Reprogramming efficiency
(Normalized for cloning efficiency)
Mean efficiency
+/2 S.E.M.
SMPs Expt 1 18/300 (6.0%) 25% 24% 23+/23%
Expt 2 4/120 (3.3%) 20% 17%
Expt 3 5/120 (4.2%) 15% 28%
Expt 4 6/60 (10.0%) ND - n/a
Sca1+ Expt 1 4/120 (3.3%) 15% 22% 29+/27%
Expt 2 5/120 (4.2%) 12% 36%
Expt 3 2/60 (3.3%) ND - n/a
Expt 4 4/60 (6.6%) ND - n/a
CXCR42 Expt 1 0/120 (0.0%) 12% 0% 0%
Expt 2 0/120 (0.0%)
Cloning efficiency of sorted cells was determined by plating each of the indicated cell types into 96-well plates, one cell per well, and counting the number of wells
containing live cells after 7 days. ND: not determined.
doi:10.1371/journal.pone.0026406.t002
Figure 4. Increased efficiency of reprogramming of SMPs and
Sca1+ cells is independent of initial levels of endogenous
expression of reprogramming factors. Quantitative real-time PCR
using primers that detect endogenously expressed Oct4, Sox2, Klf4, and
cMyc mRNAs was performed on freshly sorted SMPs, Sca1+ cells and
CXCR42 cells (A) and on reprogrammed SMP and Sca1+ iPS cells and
mES cells (three different lines tested for each cell type, B). None of the
freshly-isolated myofiber-associated cell populations expresses Oct4 or
Sox2 at appreciable levels compared to pluripotent cells. SMPs and
CXCR42 cells express Klf4 and c-Myc at significantly higher levels than
in Sca1+ cells. Data are normalized for beta2-microglobulin expression
and presented as mean +/2 S.E.M. for the indicated number of
replicates. *p,0.05; **p,0.001.
doi:10.1371/journal.pone.0026406.g004
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retain increased expression of some mRNAs associated with their
somatic cell origin (e.g., b1-integrin and CXCR4; [8]), iPS cell
epigenetic memory is not in this case sufficient to drive
differentiation of teratoma cells down a predominantly skeletal
muscle fate.
Figure 5. Teratomas from SMP iPS and Sca1+ iPS cells do not show biased differentiation into skeletal muscle by histology. (A)
Representative image of an H&E stained section of a teratoma formed from SMP iPS cells (A). The presence of skeletal muscle in teratomas from mES,
SMP iPS or Sca1+ iPS was assessed by histology, and is shown as the percent area of the tumor occupied by muscle (B). No significant differences
were detected in the fraction of striated muscle present in teratomas derived from mES, SMP iPS or Sca1+ iPS cells.
doi:10.1371/journal.pone.0026406.g005
Figure 6. Teratomas from SMP iPS and Sca1+ iPS cells do not show biased differentiation into skeletal muscle by Western blot. (A)
Representative Western blots of teratomas from SMP iPS, Sca1+ iPS, or mES cells, stained with the indicated antibodies against skeletal muscle myosin
heavy chain (MyHC), cytokeratin 8 (CK8), cytokeratin 14 (CK14) or GAPDH as a control. Three different lines were used for each pluripotent cell type to
generate the teratomas. (B) Western blots were quantified by optical densitometry using ImageJ, and results reported for MyHC (top), CK8 (middle)
and CK14 (bottom) as mean intensity (arbitrary units), normalized to the loading control (GAPDH). Error bars reflect standard error. No significant
differences were detected in the presence of MyHC (a mesodermal and skeletal muscle marker) or CK8 (an endodermal marker) among any of the
three sources of pluripotent cells. SMP iPS showed 2–3 fold greater representation of CK14 (an ectodermal marker) than Sca1+ iPS or mES. N.D. – not
detectable.
doi:10.1371/journal.pone.0026406.g006
Skeletal Muscle Stem Cell iPS Cells
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Taken together, our observations that SMPs and Sca1
+
mesenchymal progenitors reprogram to generate iPS cells with
greater efficiency than differentiated CXCR4
2 cells suggests that
pluripotency can be induced more efficiently in stem cells as
compared to their more differentiated progeny residing within the
same anatomical location and same developmental lineage. In
combination with a recent report [7], our data suggest that
increased susceptibility to reprogramming may be a common
attribute of many adult stem cells. These data thus emphasize the
crucial impact of differentiation stage on reprogramming efficien-
cy, and indicate that much higher efficiencies of iPS derivation can
be obtained simply by selecting an appropriate target population;
using undifferentiated precursor cells as targets for reprogramming
substantially enhances the efficiency of iPS generation. Future
studies identifying the molecular differences between immature
and mature cell populations should reveal critical barriers inherent
to the reprogramming process and thereby facilitate effective
generation of iPS cells for disease modeling, drug discovery and
cell therapy approaches.
Our data also indicate that, despite some epigenetic memory of
their somatic cell of origin [8], SMP iPS show no myogenic bias in
their differentiation in teratoma assays, as assessed by both
histological analysis and Western blotting for lineage-specific
differentiation markers. Similarly, although Sca1+ cells are
uniformly non-myogenic in vivo and in vitro, iPS cells generated
from Sca1+ cells differentiate to form skeletal muscle as efficiently
as SMP iPS. Intriguingly, these findings contrast with a recent
report that mesangioblast-derived iPS cells (MAB-iPS) generate
teratomas containing up to 70% striated muscle [18]. Differences
in these results may reflect differences in the degree of lineage
specification among these two cells types, as mesangioblasts have
been reported to retain both myogenic and non-myogenic
differentiation capacity (including the ability to differentiate to
form endothelium, fibroblasts, bone, fat, cartilage and neural cells),
while SMPs represent lineage-committed muscle stem cells [2].
Alternatively, it is possible that the serial passaging and selection
employed in the culture-based isolation of mesangioblasts
introduces changes in these cells that influence the subsequent
activity of iPS cells derived from them. Of note, the mesangioblasts
(MAB) that Quattrocelli et al isolated were obtained from murine
skeletal muscle and reported to derive from Sca1+ and PDGFRa+
cells. Whereas the freshly isolated SMPs studied here are
uniformly Sca12 and PDGFRa2, the ‘‘Sca1+ cells’’ in our
isolations contain ,30% PDGFRa+ cells (Figure 7), suggesting
that the Sca1+ population we studied is likely to contain a
substantial fraction of mesangioblasts. Nonetheless, in our studies,
Sca1+ iPS, like SMP iPS, generated teratomas containing only
,5% skeletal muscle (by surface area), with no differences in the
presence of skeletal muscle myosin heavy chain (determined by
Western blotting and densitometry). Thus, unlike prior studies of
iPS derived from mouse hematopoietic cells [8], and recent studies
of iPS derived from human pancreatic islets [9], each of which
reported an increased propensity of iPS to differentiate into
somatic cells of the same lineage as the iPS cell-of-origin, our data
indicate that the myogenic potential of the target cell is insufficient,
in and of itself, to impose subsequent differentiation biases on early
passage reprogrammed iPS cells. These findings are consistent
with a model in which cell-of-origin is only one of many possible
influences on the differentiation potential of iPS cells derived from
distinct somatic cells, and may reflect an incompatibility of the
myogenic program with pluripotency that may help to explain
difficulties encountered in attempts to direct the differentiation of
these cells along the skeletal muscle lineage. Thus, while
differentiation biases imparted to iPS cells based on their cell-of-
origin may be useful for deriving some somatic tissue types, they
may not provide a universal advantage for directing pluripotent
cell differentiation.
Materials and Methods
SMP isolation
Myofiber-associated cells were prepared from intact limb
muscles (EDL, gastrocnemius, quadriceps, soleus, TA, and triceps
brachii) as described previously [2,19]. Briefly, intact mouse limb
muscles were digested with collagenase II to dissociate individual
myofibers. These were triturated and digested with collagenase II
and dispase to release myofiber-associated cells. The myofiber-
associated cells were next subfractionated by FACS, using the
following marker profiles for each population: 1) SMPs: CD45
2
Mac-1
2 Sca-1
2 b1-integrin
+ CXCR4
+; 2) Myoblast and fibro-
Figure 7. Sca1+ cells but not SMPs contain a PDGFRa+ population. Sca1+ cells or SMPs were stained for PDGFRa and analyzed by FACS.
Representative FACS plots show that only Sca1+ cells (left) contain a substantial population of PDGFRa+ cells (,30% of Sca1+ cells), whereas SMPs
(right) are PDGFRa2.
doi:10.1371/journal.pone.0026406.g007
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2 Mac-1
2 Sca-1
2CXCR4
2;3 )
Sca1
+ mesenchymal cells: CD45
2 Mac-1
2 Sca-1
+. After the initial
sort, cells were re-sorted by FACS using the same gating profile to
increase the purity of the obtained population [20].
Reprogramming of myofiber-associated cells
Sorted cells from mice containing dox-inducible Oct4, Sox2, c-
Myc and Klf4 transgenes were cultured on irradiated MEFs, in ES
medium in the presence of doxycycline (10 ug/ml; Sigma D9891-
25). Doxycycline was removed once emergent iPS colonies became
stably reprogrammed (generally 21–28 days).
Generation of reprogrammable mice
Generation of the reprogrammable mouse was described in
[11,12,13]. Briefly, iPS cells were initially derived from a neonatal
tail fibroblast-derived iPS clone that was injected into blastocysts to
produce fetal liver cells. The iPS-derived fetal liver cells were
harvested and differentiated in vitro into CD8+ cells, which then
were re-induced with dox to produce iPS cells. These secondary iPS
cells were then injected into blastocysts to generate reprogrammable
mice as used in this study.
Quantitative PCR
SMPs, Sca1+ and CXCR42 cells were harvested from mouse
skeletal muscle, and double-sorted for purity. After the second sort,
cells were deposited in Trizol and cDNA was prepared using
Superscript III Reverse Transcriptase Supermix kit (Invitrogen,
11752-050). Real-time quantitative PCR reactions were carried out
in an ABI 7900 machine, using SYBR Green PCR mix (Applied
Biosystems, 4309155). Beta 2 microglobulin (B2M) was used as a
housekeeping gene, and gene expression levels normalized to B2M
expression. Primers used to amplify endogenous genes were (listed
59 to 39; sequences from [14]):
c-Myc: AAGAGGACTTGTTGCGGAAA and TTGTAATC-
CAGAGGTTGATTATCG
Klf4: ATGGTCAAGTTCCCAGCAAG and TGATATCGA-
ATTCCGTTTGTTT
Oct4: AGTTGGCGTGGAGACTTTGC and CAGGGCTT-
TCATGTCCTGG
Sox2: GGCCATTAACGGCACACT and AAGCAGCGTA-
TCCACATAGC
B2m: TTCTGGTGCTTGTCTCACTGA and CAGTATGT-
TCGGCTTCCCATTC
Cell culture media
Embryonic stem cell media consisted of high glucose DMEM
(Gibco 11965-092) supplemented with 15% ES-qualified fetal
bovine serum (FBS; Gemini), 1 mM L-Glutamax (Invitrogen
35050-061), 100 U/ml penicillin and 100 U/ml streptomycin
(Invitrogen 15070-063), 1 mM sodium pyruvate (Invitrogen
11360-070), 16 non-essential amino acids (Invitrogen 11140-
050), 0.1 mM ß-mercaptoethanol (Invitrogen 21985-023), 1000
units/ml LIF (ESGRO, Millipore).
Immunostaining and alkaline phosphatase staining
Immunostaining was performed with antibodies to Oct4
(Abcam ab19857) and SSEA-1 (Chemicon MAB4301). Alkaline
phosphatase staining was performed using the Leukocyte Alkaline
Phosphatase kit from Sigma (86R-1KT) according to manufac-
turer’s instructions.
Myogenic differentiation assays. Freshly sorted cells were
plated at 1610
4 cells/ well in 96 well plates, coated with 1 mg/ml
rat-tail collagen (Sigma) and 10 mg/ml natural mouse laminin
(Invitrogen). Cells were expanded for 5–7 days in growth medium
(GM) composed of Ham’s F10 (Invitrogen)+20% horse serum
(Atlanta Biologicals)+1% penicillin/ streptomycin+5 ng/ml bFGF
(Sigma). bFGF was replaced daily. After 5–7 days, cells were
passaged and replated onto 0.2% Matrigel (Fisher) coated
chamber slides in growth medium for 2 days, and then medium
was changed to differentiation medium (DM) consisting of Ham’s
F10+2% horse serum+1% penicillin/ streptomycin. Cells were
kept in DM for 6 days, then medium was aspirated and cells
were fixed with 4% paraformaldehyde and processed for
immunofluorescence [4].
Adipogenic differentiation assay. Freshly sorted cells were
expanded as described above. After 5–7 days, cells were replated
onto 0.2% Matrigel coated 48-well plates in growth medium for 2
days. Subsequently, medium was changed to adipogenic induction
medium consisting of DMEM+10% FBS+1% penicillin/
streptomycin+1 mM Dexamethasone (Sigma)+100 nM Insulin
(Sigma)+1 mM Roziglitazone (Cayman Chemical)+0.5 mM 3-
isobutyl-1-methylxanthine (Sigma) for 2 days, and then replaced
with adipogenic differentiation medium consisting of DMEM+10%
FBS+1% penicillin/ streptomycin+100 nM Insulin. Cells were kept
in this medium for 6 days, and then fixed with 4% Parafor-
maldehyde and stained with Oil Red O (Sigma) for one hour at
room temperature [21]. Oil Red O staining of lipid droplets within
adipocytes was analyzed by standard microscopy using an Olympus
IX51 inverted microscope.
Teratoma formation. To generate teratomas, pluripotent
cells were injected subcutaneously into the back of NOD/SCID
mice. Mice were sacrificed when tumors reached approximately
0.5 cm in diameter, and tumors were harvested for fixation and
sectioning, or for protein analysis via western blots.
Western blots. Teratomas were flash frozen in liquid nitrogen,
and homogenized in buffer containing protease inhibitors (cOmplete
protease inhibitors, Roche). The homogenate was centrifuged, and
supernatant taken for protein analysis. Protein concentration was
determined using a BCA protein assay kit (Pierce), and samples were
run on a 4–20% polyacrylamide gel (Criterion, BioRad). Proteins were
transferred onto a PVDF membrane (Immuno-Blot, BioRad), and
blocked with 5% nonfat dry milk. Primary antibody staining was done
in Tris-buffered saline (Atlanta Biologicals) with 0.1% Tween-20
containing 5% milk at 4uC overnight on a rocking platform.
Secondary antibody staining was done in 5% milk at room
temperature for 1 hour on a rocking platform. Protein bands were
visualized using enhanced luminescence reagents (Amersham
RPN2232) and quantified using a Typhoon Imager (Amersham).
Band intensities were quantified using ImageJ (National Institutes of
Health). Antibodies used were as follows: Anti-GAPDH (Abcam
ab9485), Anti-skeletalfastmyosinheavy chain(Abcamab91506), Anti-
cytokeratin 14 (Abcam ab7800), Anti-cytokeratin 8 (Developmental
Studies Hybridoma Bank, Troma-1), Anti-Mouse IgG Peroxidase
Conjugated (Thermo Scientific 31430), Anti-Rabbit IgG Peroxidase
Conjugated (Thermo Scientific 31460), Anti-Rat IgG Peroxidase
Conjugated (Thermo Scientific 31470). Optical densitometry was
done using ImageJ according to http://lukemiller.org/index.php/
2010/11/analyzing-gels-and-western-blots-with-image-j/.
Animal welfare
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Massachusetts General Hospital
Subcommittee on Research Animal Care (Protocol number
2006N000104 to Konrad Hochedlinger) and the Joslin Diabetes
Center Institutional Animal Care and Use Committee (Protocol
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Committee on the Use of Animals in Research and Teaching
(Protocol 29-14 to Amy Wagers). All surgeries were performed
under anesthesia, and all efforts were made to minimize suffering.
Animals were humanely sacrificed prior to tissue collection. iPS
cells were generated in accordance with the approved protocols
from Massachusetts General Hospital (Protocol number
2006N000104 ), Joslin Diabetes Center (Protocol 04-01) and
Harvard University (Protocol 29-14) as stated above.
Supporting Information
Figure S1 Generation of ‘‘reprogrammable mice’’ and
experimental design to test reprogramming efficiency of
myofiber-associated cells. Induced pluripotent stem cells (iPS
cells) were generated from mouse tail-tip fibroblasts by infection
with lentiviruses containing doxycycline-inducible Oct4, Sox2,
Klf4 and c-myc transgenes. Addition of doxycycline (dox) induces
reprogramming. These iPS cells were injected into e3.5 mouse
blastocysts, where they contributed to fetal liver. Fetal liver cells
were harvested, differentiated into CD8+ cells, and dedifferenti-
ated again using dox. The resulting iPS cells were used to generate
the reprogrammable mice for this study. The limb muscles of these
reprogrammable mice were harvested to myofiber-associated cells,
which were cultured in the presence of dox to produce tertiary iPS
cells. Muscle-derived iPS cells were used to generate transgenic
mice, which when bred to wild-type mice demonstrated germline
transmission.
(PDF)
Figure S2 Bulk-sorted SMPs and Sca1+ cells reprogram
more efficiently compared to CXCR42 myoblasts. (A)
Myofiber-associated cells were isolated from chimeric mice,
transgenic for dox-inducible Oct4, Sox2, Klf4 and c-myc (but
not tdTomato). Doxycycline was added to induce transgene
expression of Oct4, Sox2, Klf4 and c-myc. These cells consist of a
mix of transgenic and non-transgenic cells; therefore, analysis of
these cell populations, underestimates the reprogramming effi-
ciency of each cell type. Reprogramming efficiencies reported in
(B) are given as the percent of input cells (per number of cells
seeded) generating colonies with embryonic stem cell-like
morphology after 3 weeks. ND: not determined.
(PDF)
Figure S3 Representative FACS plots of tdTomato+ cells
sorted from the myofiber-associated cell compartment
for reprogramming. FACS gating of the indicated cell
populations is indicated by blue boxes and red arrows. The
percent of cells within each gate is as shown. tdTomato-expression
indicates the presence of cells transgenic for the four dox-inducible
reprogramming factors in all the populations (Sca-1+ (top),
CXCR42 (middle), and SMP (bottom)).
(PDF)
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